Abstract

BackgroundCervical cancer remains the major public problem worldwide and the most common gynaecological malignancy in the developing world, particularly in sub-Saharan Africa.AimTo determine the prevalence of abnormal cervical cytology amongst women with and without human immunodeficiency virus (HIV) and examine the association between HIV and histological grading.SettingThe study was conducted in Limpopo province, which is the northernmost province of South Africa. The province has five district municipalities with one tertiary, five regional and thirty four district hospitals.MethodsWe retrospectively reviewed cervical cancer cases in Limpopo province (LP) of South Africa, using data collected routinely by the National Health Laboratory Services (NHLS). The data on smears submitted for cytology between 2013 and 2015 were extracted from the Central Data Warehouse (CDW) database.ResultsA total of 84 466 women were screened for cervical cytology smears. Their mean age was 39.8 ± 13.6 years, with range from 15 to 113 years; 77.2% were in the age group 30 years and older and 19.6% had an abnormal cervical cytology result. Overall, 46.4% of the women screened for cervical cancer were HIV infected. A significantly higher proportion of HIV-positive women had abnormal cytology than HIV-negative women (31.8% vs. 9.2%).ConclusionThe prevalence of abnormal cytology amongst HIV-positive women is relatively high, and the risk appears to be significantly greater in all age groups. This finding highlights the need to ascertain HIV status of all women presenting with cervical cancer.

Highlights

  • Human papillomavirus has been known to increase with age; some age groups remain at higher risk of CC, especially those living with human immunodeficiency virus (HIV)

  • The prevalence of abnormal cytology was significantly higher amongst HIV-positive women than amongst women who tested HIV-negative (p < 0.05; Figure 2)

  • Our finding shows that the prevalence of cervical lesions amongst HIV-positive women was 31.8%, which was significantly higher than 9.2% in HIV-negative women

Read more

Summary

Introduction

Cervical cancer (CC) is the most common gynaecological malignancy in the developing world, in sub-Saharan Africa.[1,2] Prevention of complications and improved survival from CC depend on early detection, treatment and human papillomavirus (HPV) vaccination before any sexual debut.[3,4] Human papillomavirus has been known to increase with age; some age groups remain at higher risk of CC, especially those living with human immunodeficiency virus (HIV). Cervical cancer remains the major public problem worldwide and the most common gynaecological malignancy in the developing world, in sub-Saharan Africa

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.